← Leaderboards
Kelly Wayne Broadhead
University Of Utah
$38,836
Attributed
$194,182
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $39.5K · FY2012–16$50K$37.5K$25K$12.5K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$194,182 · 1
By mechanism
R25$194,182 · 1
Top collaborators
- James Agutter5 shared
- Robert Hitchcock5 shared
- John Langell5 shared
- Tomasz J. Petelenz3 shared
- Jeffrey Wolchok2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Susan L Thibeault$24,991,429
- David J Stillman$11,832,241
- Ching-Kang Jason Chen$11,526,143
- Jeffrey A. Weiss$16,889,073
- Patrick Franklin Kiser$17,126,760
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseFeedingBusinessesCareerClinicArchitectureCommercializationCost EffectiveDesignDevice DesignsDevicesEconomicsClinically RelevantBiomedical EngineeringEducational CurriculumEducational Process Of InstructingEmpoweredEngineeringEngineering DesignEnrollmentEnvironmentEthicsFamilyFostering
Grant awards (5)
USING CLINICAL IMMERSION AS AN EMPATHETIC TRAINING TOOL IN MEDICAL DEVICE INNOVAT$38,858
R25 · FY2016 · EB
USING CLINICAL IMMERSION AS AN EMPATHETIC TRAINING TOOL IN MEDICAL DEVICE INNOVAT$39,506
R25 · FY2015 · EB
USING CLINICAL IMMERSION AS AN EMPATHETIC TRAINING TOOL IN MEDICAL DEVICE INNOVAT$39,506
R25 · FY2014 · EB
USING CLINICAL IMMERSION AS AN EMPATHETIC TRAINING TOOL IN MEDICAL DEVICE INNOVAT$39,506
R25 · FY2013 · EB
USING CLINICAL IMMERSION AS AN EMPATHETIC TRAINING TOOL IN MEDICAL DEVICE INNOVAT$36,806
R25 · FY2012 · EB